HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Shimizu Selected Research

Krypton-81

11/2000Beneficial effect of combination therapy with ozagrel and pranlukast in exercise-induced asthma demonstrated by krypton-81 m ventilation scintigraphy--a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Shimizu Research Topics

Disease

25Neoplasms (Cancer)
12/2017 - 04/2000
14Bullous Pemphigoid (Pemphigoid)
04/2021 - 08/2000
8Pemphigus (Pemphigus Vulgaris)
01/2019 - 04/2000
8Wounds and Injuries (Trauma)
11/2008 - 03/2000
7Inflammation (Inflammations)
02/2016 - 06/2001
6Hypertension (High Blood Pressure)
10/2015 - 01/2000
6Atherosclerosis
12/2010 - 03/2000
5Neoplasm Metastasis (Metastasis)
12/2017 - 12/2000
5Breast Neoplasms (Breast Cancer)
01/2017 - 09/2000
5Obesity
03/2016 - 03/2001
5Stomach Neoplasms (Stomach Cancer)
02/2016 - 07/2000
5Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
03/2015 - 01/2000
5Infections
03/2009 - 07/2000
4Atopic Dermatitis (Atopic Eczema)
01/2017 - 08/2009
4Pancreatic Neoplasms (Pancreatic Cancer)
07/2010 - 03/2008
4Skin Diseases (Skin Disease)
01/2009 - 09/2002
4Benign Familial Pemphigus (Hailey Hailey Disease)
01/2006 - 04/2000
4Body Weight (Weight, Body)
07/2005 - 02/2001
4Darier Disease (Darier's Disease)
04/2004 - 04/2000
4Rupture
04/2002 - 01/2000
3Erythema
04/2018 - 11/2001
3Drug Eruptions (Drug Eruption)
02/2017 - 07/2003
3Adenocarcinoma of Lung
01/2017 - 09/2001
3Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris)
01/2017 - 08/2009
3Pain (Aches)
01/2017 - 01/2006
3Insulin Resistance
01/2016 - 09/2000
3Blister (Bulla)
05/2012 - 10/2003
3Psoriasis (Pustulosis Palmaris et Plantaris)
02/2009 - 06/2001
3Acantholysis
11/2008 - 04/2000
3Epidermolysis Bullosa
04/2008 - 08/2000
3Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
08/2006 - 04/2000
3Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)
10/2003 - 02/2001
3Human Influenza (Influenza)
12/2001 - 01/2000
3Heart Failure
11/2001 - 01/2001
3Heart Diseases (Heart Disease)
07/2001 - 03/2001
3Diabetes Mellitus
04/2001 - 07/2000
3Drug Resistant Epilepsy
03/2001 - 09/2000
2Melanoma (Melanoma, Malignant)
12/2017 - 10/2017
2Mycosis Fungoides
07/2017 - 01/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2017 - 04/2008
2Lung Neoplasms (Lung Cancer)
01/2017 - 06/2014
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2017 - 04/2001
2Lamellar Ichthyosis (Harlequin Ichthyosis)
01/2017 - 01/2003
2Thrombosis (Thrombus)
01/2017 - 10/2004
2Skin Ulcer
03/2016 - 05/2005
2Metabolic Diseases (Metabolic Disease)
01/2016 - 06/2006
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
11/2015 - 01/2000
2Exercise-Induced Allergies
04/2015 - 01/2009

Drug/Important Bio-Agent (IBA)

15AutoantibodiesIBA
04/2021 - 11/2000
10Messenger RNA (mRNA)IBA
04/2010 - 03/2000
9Immunoglobulin G (IgG)IBA
04/2021 - 07/2000
9Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2000
8EnzymesIBA
02/2015 - 01/2000
6Filaggrin ProteinsIBA
01/2018 - 08/2009
6Matrix Metalloproteinases (MMPs)IBA
05/2012 - 03/2000
6Heme (Haem)IBA
11/2008 - 03/2000
5Tacrolimus (Prograf)FDA LinkGeneric
11/2015 - 12/2002
5Collagen Type VIIIBA
03/2015 - 10/2000
5Glycine (Aminoacetic Acid)FDA LinkGeneric
08/2009 - 01/2000
5Heme Oxygenase-1IBA
11/2008 - 03/2000
4Immunoglobulin A (IgA)IBA
06/2017 - 01/2002
4Cadherins (E-Cadherin)IBA
02/2016 - 04/2000
4Glucose (Dextrose)FDA LinkGeneric
11/2015 - 02/2000
4Pharmaceutical PreparationsIBA
10/2012 - 07/2000
4LeptinIBA
02/2009 - 03/2001
4Adrenal Cortex Hormones (Corticosteroids)IBA
09/2007 - 11/2000
4Keratins (Keratin)IBA
08/2006 - 01/2000
4AntigensIBA
01/2004 - 08/2000
4AntibodiesIBA
09/2001 - 07/2000
3Immunosuppressive Agents (Immunosuppressants)IBA
11/2012 - 09/2005
3RNA (Ribonucleic Acid)IBA
08/2012 - 04/2000
3Collagen Type XVIIIBA
05/2012 - 08/2000
3Biological ProductsIBA
08/2011 - 01/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011 - 03/2006
3Protein Isoforms (Isoforms)IBA
07/2008 - 10/2001
3Amino AcidsFDA Link
10/2006 - 10/2000
3Codon (Codons)IBA
10/2006 - 01/2000
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2005 - 01/2001
3Neuraminidase (Sialidase)IBA
12/2001 - 01/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2001 - 07/2000
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2001 - 09/2000
3CholesterolIBA
01/2001 - 07/2000
2Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 07/2000
2GoldIBA
04/2018 - 06/2014
2Surface-Active Agents (Surfactants)IBA
01/2017 - 09/2000
2LipidsIBA
01/2017 - 01/2016
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 11/2005
2MucinsIBA
02/2016 - 01/2000
2salicylhydroxamic acid (SHAM)IBA
01/2016 - 07/2000
2Triglycerides (Triacylglycerol)IBA
01/2016 - 10/2015
2Small Interfering RNA (siRNA)IBA
02/2015 - 05/2008

Therapy/Procedure

27Therapeutics
01/2021 - 01/2000
3Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2016 - 04/2001
3Drug Therapy (Chemotherapy)
04/2012 - 12/2000
3Liver Transplantation
02/2011 - 05/2002
3Lasers (Laser)
06/2009 - 09/2001
3Dye Lasers
10/2005 - 11/2003
3Transcranial Magnetic Stimulation
01/2002 - 09/2000
3Hemispherectomy
03/2001 - 09/2000
3Hepatectomy
08/2000 - 05/2000